AI assistant
Sending…
RAPT Therapeutics, Inc. — Director's Dealing 2021
Oct 19, 2021
32942_dirs_2021-10-19_ed58f2d3-7c7e-4982-b800-a4080e5afcc8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2021-10-18
Reporting Person: Robbins Wendye (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-18 | Common Stock | P | 500 | $30.7 | Acquired | 9300 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1300 | Indirect |
| Common Stock | 305 | Indirect |
| Common Stock | 2000 | Indirect |
More from RAPT Therapeutics, Inc.
Regulatory Filings
2026
Mar 18
M&A Activity
2026
Mar 3
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 9
Merger & Acquisition
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2